Completion of ReLink Randomized Controlled Trial: A Milestone in Healthcare Innovation

We're thrilled to announce the conclusion of the ReLink randomized controlled trial, with the enrollment of the final patient marking a monumental achievement in healthcare innovation. As we eagerly await the results, we anticipate sharing insights that could significantly shape the future of patient care. Stay tuned for upcoming updates!

Completion of ReLink Randomized Controlled Trial